NAVIDEA BIOPHARMACEUTICALS, INC. Public Float
NAVIDEA BIOPHARMACEUTICALS, INC. had Public Float of $14.27 million as of 2022-06-30, per its 10-K filed 2023-03-27.
Discontinued › Notes › Cover Page
dei:EntityPublicFloat · last filed 2023-03-27
- 2022-06-30: Entity Public Float $14.27M.
- 2021-06-30: Entity Public Float $35.96M.
- 2020-06-30: Entity Public Float $66.32M.
- 2019-06-30: Entity Public Float $11.35M.
| Period end | Entity Public Float |
|---|---|
| 2022-06-30 | $14.27M 10-K · filed 2023-03-27 |
| 2021-06-30 | $35.96M 10-K · filed 2022-03-28 |
| 2020-06-30 | $66.32M 10-K · filed 2021-03-26 |
| 2019-06-30 | $11.35M 10-K · filed 2020-03-18 |
| 2018-06-30 | $35.84M 10-K · filed 2019-03-15 |
| 2017-06-30 | $78.56M 10-K · filed 2018-03-15 |
| 2016-06-30 | $84.03M 10-K · filed 2017-03-31 |
| 2015-06-30 | $239.81M 10-K · filed 2016-03-23 |
| 2014-06-30 | $220.52M 10-K · filed 2015-03-16 |
| 2013-06-30 | $315.34M 10-K · filed 2014-03-14 |
| 2012-06-30 | $355.92M 10-K/A · filed 2013-03-21 |
| 2011-06-30 | $300.60M 10-K · filed 2012-03-07 |